Internetiühendust pole — kuvatakse lehe salvestatud versioon.

Agios Pharm

USUSD
← Aktsiafiltri Juurde
US:AGIOLSE:0HB0

Agios Pharm (LSE:0HB0) — Biotechnology: Pharmaceutical Preparations. Börside arv, kus ettevõtte aktsiatega kaubeldakse: 2. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.

Ettevõtte Kohta

Veebileht
agios.com
Investorite Suhted
investor.agios.com/
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Peakontor
Cambridge, United States
Tegevjuht
Brian M. Goff
Töötajad
539
Asutatud
2008
Ringluses Olevad Aktsiad
59.7 mln seisuga 2026-07-24
Vabalt Kaubeldavad Aktsiad
50.02 mln
Turukapitalisatsioon
2 mld USD
Siseringi Isikud
1.07%
Institutsionaalsed Investorid
112.31%
Tegevusala (SIC)
Pharmaceutical Preparations
ISIN
US00847X1046
LEI
529900ONJHY8EOGYT555
FCF
−365 mln USD
Võlg
?
Kasum ja FCF — 12 kuu jooksul kuni 30.06.2026 (ettevõtte viimane raport).
Kirjeldus

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and AQVESME for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it developed tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and sickle cell disease; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

reklaam

Börsid ja Tikkerid

BörsTikkerValuutaHindTüüp
US USA StocksAGIO põhinoteeringUSD30.21 -1.98%tavalised aktsiad
LSE London Stock Exchange0HB0 IOBUSD33.1105 +0.00%tavalised aktsiad

Hind 3 Kuu Jooksul

3M1Y3Y5Y
tõususepäev langusepäevViige kursor / puudutage päeva — avamis-, sulgemis-, kõrgeim ja madalaim hind

Suurimad Omanikud

OmanikOsalusAktsiadAruande Kuupäev
Blackrock Inc.10.81%6.46 mln2026-06-30
Farallon Capital Managem…9.91%5.92 mln2026-06-30
State Street Corporation5.92%3.53 mln2026-06-30
Lynx1 Capital Management…5.71%3.41 mln2026-06-30
Shaw D.E. & Co., Inc.5.2%3.11 mln2026-06-30
Vanguard Portfolio Manag…4.85%2.9 mln2026-06-30
Vanguard Capital Managem…4.49%2.68 mln2026-06-30
Armistice Capital, LLC4.02%2.4 mln2026-06-30
Erste Asset Management G…3.61%2.15 mln2026-06-30
SPDR SERIES TRUST-State…3.54%2.11 mln2026-08-31
Nomura Asset Management…3.54%2.11 mln2026-06-30
VANGUARD INDEX FUNDS-Van…3.16%1.89 mln2026-06-30
iShares Trust-iShares Ru…2.52%1.51 mln2026-07-31
VANGUARD INDEX FUNDS-Van…2.28%1.36 mln2026-06-30
Delaware Group Equity Fu…1.92%1.14 mln2026-05-31
VANGUARD INDEX FUNDS-Van…1.32%788 6552026-06-30
VANGUARD INDEX FUNDS-Van…1.15%683 9902026-06-30
Fidelity Salem Street Tr…1.08%646 3182026-07-31
Fidelity Rutland Square…0.88%526 1212026-07-31
iShares Trust-iShares Ru…0.86%511 9942026-07-31
FOUSE JACQUALYN A. (Dire…≈0.26%154 1562026-06-18
GHEUENS SARAH (Officer)≈0.09%54 6452026-08-04
SCADDEN DAVID T. (Direct…≈0.03%20 4192026-06-18
HO MAYKIN (Director)≈0.03%19 8482026-06-18
BALLAL RAHUL D. (Directo…≈0.03%15 2302026-06-18
SMITH CYNTHIA (Director)≈0.03%15 2302026-06-18
FOSTER-CHEEK KAYE I (Dir…≈0.02%12 4842026-06-18
ADAMS CATHERINE OWEN (Di…≈0.02%10 8652026-06-18
CAPELLO JEFFREY D (Direc…≈0.02%10 8652026-06-18
BACKSTROM JAY T (Directo…≈0%1 4472026-07-08